University Briefs

California Schools Pair Up With Business The State of California has embarked on a matching funds program meant to take technology from the state’s universities and national laboratories and apply it in the marketplace. In May, the state’s Competitive Technology Program awarded $6.6 million in grants, matched by $6.8 million In industry funding. Among the big winners were a superconductivity consortium, made up by the University of California, Los Angeles ran four venture capital f

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The State of California has embarked on a matching funds program meant to take technology from the state’s universities and national laboratories and apply it in the marketplace. In May, the state’s Competitive Technology Program awarded $6.6 million in grants, matched by $6.8 million In industry funding. Among the big winners were a superconductivity consortium, made up by the University of California, Los Angeles ran four venture capital firms, which received a $1.2 million grant. Twelve of the other 28 successful applications also involved University of California institutions. According to Anne Sheehan, deputy director of the program, private firms benefit from the scheme through intellectual property agreements that they share with their university or national lab partners: They may receive licensing and patenting rights, for example. Grant money, however, must be used to support activities directly related to the research project. While it can be used for equipment, it cannot ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies